Study S002360

A Randomized, Double-blind, Placebo-controlled Study Evaluating the Effect of LAE102 Injection in Combination With Tirzepatide on Body Composition in Obese Participants

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT07671391
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE2
Masking: TRIPLE
Status: NOT_YET_RECRUITING
Enrollment: 60
Start: 2026-08
Primary completion: 2027-07
Lead sponsor: Shanghai Zhongshan Hospital
Conditions: Obesity Adult Onset
Interventions: DRUG:LAE102 +Tirzepatide; DRUG:LAE102 placebo,+Tirzepatide
Results posted: FALSE
Individual participant data sharing: NO

Registered primary outcomes

The percentage change in lean body mass [24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.